CN101298442A - Acidamide compound based on 2-(2'-hydroxyphenyl) benzoxazole, preparation and use thereof - Google Patents

Acidamide compound based on 2-(2'-hydroxyphenyl) benzoxazole, preparation and use thereof Download PDF

Info

Publication number
CN101298442A
CN101298442A CNA2007100989678A CN200710098967A CN101298442A CN 101298442 A CN101298442 A CN 101298442A CN A2007100989678 A CNA2007100989678 A CN A2007100989678A CN 200710098967 A CN200710098967 A CN 200710098967A CN 101298442 A CN101298442 A CN 101298442A
Authority
CN
China
Prior art keywords
benzothiazole
hydroxy phenyl
carboxylic acid
acid
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2007100989678A
Other languages
Chinese (zh)
Other versions
CN101298442B (en
Inventor
杨国强
钱妍
王双青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Chemistry CAS
Original Assignee
Institute of Chemistry CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Chemistry CAS filed Critical Institute of Chemistry CAS
Priority to CN2007100989678A priority Critical patent/CN101298442B/en
Publication of CN101298442A publication Critical patent/CN101298442A/en
Application granted granted Critical
Publication of CN101298442B publication Critical patent/CN101298442B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

The invention relates to an acid amide compound, in particular to the compound based on ESIPT, namely the acid amide compound of 2-(2'-hydroxyphenyl) benzoxazole; the compound of the invention is obtained by adding carboxylic acid and carbonyl diimidazole into a reaction solvent and reacting for 1 to 3 hours under the temperature of 25 to 40 DEG C; then adding the amine compound of the 2-(2'-hydroxyphenyl) benzoxazole and reacting for 2 to 14 hours under the temperature of 25 to 130 DEG C, filtering and purifying. The separation and purifying operations of the preparation method of the invention are simple and convenient; the reaction has no irritation and causticity and the mono-substituted, bis-substituted and tri-substituted acid amide compounds can be directly prepared. The compound of the invention has higher decomposing temperature and excellent thermal stability and can be used for preparing organic luminous materials. The structural general formula of the invention is seen in formula I, wherein, X refers to S, O or NH; when Y is equal to 1, R refers to 7-carboxyl heptane radical, etc.; when Y is equal to 2, R refers to heptane radical, etc.; when Y is equal to 3, R is triphenyl.

Description

Amides and method for making and purposes based on 2-(2'-hydroxy phenyl) benzothiazole
Technical field
The present invention relates to amides, relate in particular to based on excited state molecule inner proton transfer compounds, be 2-(2 '-hydroxy phenyl) benzothiazole (2-(2 '-hydroxyphenyl) benzoxales, HBX, X=S, O or NH) amides, and the preparation method of this compound and be used to prepare the purposes of luminous organic material aspect.
Background technology
Amides has purposes widely at aspects such as industry, agricultural chemicals, medical science, biologies.At medical field, the bioprobe with hyperfluorescence also becomes the focus of medical research field at aspects such as immune optics and immune titration.Excited state molecule inner proton transfer compounds is connected to the research of carrying out fluorescent probe on the biomolecules and also has bigger application prospect owing to its big stokes displacement and high fluorescent.
At present based on excited state molecule inner proton transfer compounds 2-(2 '-hydroxy phenyl) benzothiazole (HBX, X=S, O or NH) amides, only be the acylate of monoprotic acid and HBX aminated compounds, people such as Ermanno have prepared acid amides (Ermanno, the B. that a series of monoprotic acid replace; Piero, S.; Mario, M.; Macro, P.J.Heterocyclic.Chem.1983,20,1517).They generate corresponding acyl chlorides with the reaction of chloride reagents such as carboxylic acid compound and thionyl chloride, and acyl chlorides reacts with primary amine 2-(4-amino-2 hydroxy phenyl) benzothiazole compound again, and entire reaction is carried out in two steps.The reaction of this class is owing to relate to the application of chloride reagents such as thionyl chloride, and response stimulus is bigger, and corrodibility is stronger, and the acyl chlorides that generates also need could carry out condensation reaction with amine through purifying, and operation is inconvenience comparatively, generally should not adopt.And for diacid or three acid and amidate action based on the arylamine of HBX, this method can not reach acidylate completely.Because primary amine 2-(4-amino-2 hydroxy phenyl) benzothiazole compound has hydroxyl and amino two active groups simultaneously; there are following two problems in aforesaid method for diacid or three acid and amidate action based on the arylamine of HBX: (1) than low boiling point solvent (tetrahydrofuran (THF)) though in do not need the active group hydroxyl is protected; but experimental result shows that this only can prepare the acidylate of single carboxyl; promptly be only applicable to the preparation of the amides of mono-substituted 2-(2 '-hydroxy phenyl) benzothiazole; (2) aforesaid method then relates to the protection of hydroxyl and goes the protection problem in high boiling solvent (toluene), can't prepare whole carboxyls easily and all be replaced and trisubstituted amides by the two of acidylate.
Summary of the invention
The object of the present invention is to provide amides based on 2-(2 '-hydroxy phenyl) benzothiazole.
Another object of the present invention is to provide method for making based on the amides of 2-(2 '-hydroxy phenyl) benzothiazole.
A further object of the present invention is to provide the purposes that is used to prepare the luminous organic material aspect based on the amides of 2-(2 '-hydroxy phenyl) benzothiazole.
Amides based on 2-(2 '-hydroxy phenyl) benzothiazole (HBX X=S, O or NH) of the present invention, its general structure is:
Figure A20071009896700061
Wherein X is S, O or NH;
During Y=1, R is
Figure A20071009896700062
(7-carboxyl heptane base), (adjacent carboxyl phenyl),
Figure A20071009896700064
(carboxyl phenyl), (carboxyl phenyl between the 5-methyl), (carboxyl phenyl between the 5-tertiary butyl) or
Figure A20071009896700067
(to carboxyl phenyl); Wherein: Me is a methyl; TBu is the tertiary butyl;
During Y=2, R is
Figure A20071009896700068
(heptane base),
Figure A20071009896700069
(phenyl),
Figure A200710098967000610
(oreinol base),
Figure A200710098967000611
(phenyl between the 5-tertiary butyl) or
Figure A200710098967000612
(to phenyl); Wherein: Me is a methyl; TBu is the tertiary butyl;
During Y=3, R is
Figure A200710098967000613
(mesitylene base).
The method for making of the amides based on 2-(2 '-hydroxy phenyl) benzothiazole of the present invention, its reaction scheme is as follows:
Figure A20071009896700071
X=S,O,NH
Y=1 Y=2 Y=3
Figure A20071009896700072
Concrete synthetic method is: carboxylic acid and carbonyl dimidazoles (CDI) are joined in the reaction solvent, under 25~40 ℃ of temperature, reacted 1~3 hour, the aminated compounds that adds 2-(2 '-hydroxy phenyl) benzothiazole (HBX) again, reacted 2~14 hours under 25~130 ℃ of temperature, filtration, purifying promptly obtain compound of the present invention.
Described carboxylic acid structure general formula is:
Figure A20071009896700073
Y=1,2 or 3 wherein, R is same as above.
When Y=1, reaction solvent is an anhydrous tetrahydro furan; When Y=2 or 3, reaction solvent is a dry toluene.
Count in molar ratio, the ratio of described carboxylic acid and carbonyl dimidazoles is 1: 0.9Y~1.5Y, preferred 1: 1.2Y; The ratio of the aminated compounds of described carboxylic acid and 2-(2 '-hydroxy phenyl) benzothiazole (HBX) is 1: 0.5Y~1.4Y, preferred 1: 1Y; Y=1,2 or 3 wherein.
The ratio of described carboxylic acid and reaction solvent is 1 mole: 3Y~10Y liter, preferred proportion are 1 mole: 4Y~7Y liter; Y=1,2 or 3 wherein.
Described carboxylic acid, carbonyl dimidazoles use the commercial goods;
Described carboxylic acid is: pimelic acid, phthalic acid, m-phthalic acid, oreinol dioctyl phthalate, 5-tert-butyl isophthalic acid, terephthalic acid or trimesic acid
The aminated compounds of described 2-(2 '-hydroxy phenyl) benzothiazole (HBX), its general structure is as follows, can adopt document Ermanno, B.; Piero, S.; Mario, M.; Macro, P.J.Heterocyclic.Chem.1983,20,1517 method preparation.
Figure A20071009896700081
Wherein X is S, O or NH.
Amides based on 2-(2 '-hydroxy phenyl) benzothiazole of the present invention is far longer than luminous intensity in the solution in the fluorescence intensity under solid-state, can be used for preparing luminous organic material etc.
Amides of the present invention, can under the situation that need not separate purification, carry out the condensation reaction of next step carboxylic acid, reaction yield can reach more than 70%, product separation purification operations is easy, reaction nonirritant, non-corrosiveness, and can directly prepare single replacement, two replacement and trisubstituted amides, this compounds has higher decomposition temperature and good thermostability.
Description of drawings
Fig. 1. absorption spectrum and the luminescent spectrum of amides in tetrahydrofuran solution of 2-(2 '-hydroxy phenyl) benzothiazole of the embodiment of the invention 4 preparations.
Fig. 2. absorption spectrum and the luminescent spectrum of amides in tetrahydrofuran solution of 2-(2 '-hydroxy phenyl) benzothiazole of the embodiment of the invention 5 preparations.
Fig. 3. the differential scanning calorimetric curve of the amides of 2-(2 '-hydroxy phenyl) benzothiazole of the embodiment of the invention 4 (solid line) and embodiment 5 (dotted line) preparation.
Fig. 4. the thermogravimetric analysis curve of the amides of 2-(2 '-hydroxy phenyl) benzothiazole of the embodiment of the invention 4 (solid line) and embodiment 5 (dotted line) preparation.
Fig. 5. the amides of 2-(2 '-hydroxy phenyl) benzothiazole of the embodiment of the invention 4 preparation is at tetrahydrofuran solution luminescent spectrum and the photo under ultraviolet lamp of its aggregate in aqueous dispersion that neutralize.
Fig. 6. the amides of 2-(2 '-hydroxy phenyl) benzothiazole of the embodiment of the invention 5 preparation is at tetrahydrofuran solution luminescent spectrum and the photo under ultraviolet lamp of its aggregate in aqueous dispersion that neutralize.
Embodiment
Embodiment 1~3 is the preparation example of the aminated compounds of 2-(2 '-hydroxy phenyl) benzothiazole (HBX).
Embodiment 1
Preparation 2-(4 '-amino-2 '-hydroxy phenyl) benzothiazole is pressed document 1 (Ermanno, B.; Piero, S.; Mario, M.; Macro, P.J.Heterocyclic.Chem.1983,20,1517) synthetic the obtaining of method, its molecular structural formula is:
Figure A20071009896700091
Adjacent amino-benzene mercaptan of 12.2g (0.1mol) and 15.1g 4-aminosallcylic acid (0.1mol) are added in the polyphosphoric acid (PPA) of 100ml; under the condition of logical nitrogen protection, stirred 6 hours in 160 ℃; NaOH solution and NaHCO are used again successively with a large amount of frozen water dilutions in reaction solution cooling back 3Solution transfers to neutrality, separates out a large amount of precipitations, with its filtration, obtains light xanchromatic head product (86%).Use ethyl acetate again: the quick silicagel column of crossing of the eluent of hexanaphthene=3: 1 (volume ratio) is with purifying products.
Embodiment 2
Preparation 2-(4 '-amino-2 '-hydroxy phenyl) benzo Dumb azoles obtains by the method for document 1 is synthetic, and its molecular structural formula is:
Figure A20071009896700092
The adjacent amino-benzene mercaptan of raw material is changed to other step method of Ortho-Aminophenol with embodiment 1,
Embodiment 3
Preparation 2-(4 '-amino-2 '-hydroxy phenyl) benzoglyoxaline obtains by the method for document 1 is synthetic, and its molecular structural formula is:
Figure A20071009896700101
The adjacent amino-benzene mercaptan of raw material is changed to other step method of O-Phenylene Diamine with embodiment 1,
Embodiment 4~13 is the preparation example based on the amides of 2-(2 '-hydroxy phenyl) benzothiazole (HBX), and the aminated compounds of 2-(2 '-hydroxy phenyl) benzothiazole (HBX) that is prepared by embodiment 1~3 and diprotic acid or triprotic acid reaction obtain.
Embodiment 4
Preparation N, N '-two (3-hydroxyl-4-(2 '-benzothiazole) phenyl) isophthaloyl amine, its molecular structural formula is:
X=S wherein, Y=2, R=
Figure A20071009896700103
With m-phthalic acid 0.415g (2.5mmol) and 0.972g 1,1 '-carbonyl dimidazoles CDI (6mmol) adds in the 30ml toluene, and 40 ℃ were reacted 3 hours, and added 1.21g 2-(4-amino-2 hydroxy phenyl) benzothiazole (5mmol) again, back flow reaction 6 hours.With reacting liquid filtering, get crude product 1.21g, yield is 82.4%.Product CH 2Cl 2/ CH 3(v/v=10: 1) mixed solvent washs and obtains purifying OH.Compound M.p.388 ℃. 1H-NMR (400Hz, d-DMSO) δ=11.71 (2H, s), δ=10.66 (2H, s), δ=8.57 (1H, s), δ=8.19 (4H, dd, J=8.40,3.45), δ=8.13 (2H, d, J=7.84), δ=8.03 (2H, d, J=8.06), and δ=7.83 (2H, d, J=1.63), δ=7.74 (1H, t, J=7.74), δ=7.54 (2H, t, J=7.59), δ=7.44 (4H, d, J=8.04) MALDI-TOF, m/z:615.4, ultimate analysis (C 34H 22N 4O 4S 2): C 0.6643, and H 0.0361, N0.0911; Measured value: C 0.6636, H 0.0359, and N 0.0921.As shown in Figure 1, the characteristic feature that the big stokes displacement of 150nm is an excited state molecule inner proton transfer compounds in the spectrum.Shown in solid line in the differential calorimetric scanning curve of Fig. 3, its fusing point is respectively 388 ℃, illustrates that they have thermostability preferably.Shown in solid line in the thermogravimetric curve of Fig. 4,, illustrated that equally it has higher decomposition temperature and good thermostability almost there not being the thermogravimetric loss below 400 ℃.In addition as shown in Figure 5 product in state of aggregation or the fluorescent emission intensity when solid-state much larger than its luminous intensity in solution, can be applicable to the organic molecule field of light emitting materials.
Embodiment 5
Preparation N, N '-two (3-hydroxyl-4-(2 '-benzothiazole) phenyl) the 5-tertiary butyl-benzene first diamide, its molecular structural formula is:
Figure A20071009896700111
X=wherein, Y=, R=
Change the m-phthalic acid among the embodiment 4 into the 5-tertiary butyl-m-phthalic acid, CDI is changed to 7.5mmol, toluene 15ml, and 2-(4-amino-2 hydroxy phenyl) benzothiazole is changed to 7mmol, and other step is with embodiment 4.Filter gained crude product methylene dichloride (CH 2Cl 2) the solvent repeated washing.Compound M.p.322 ℃. 1H-NMR (400Hz, d-DMSO) δ=11.74 (2H, s), δ=10.63 (2H, s), δ=8.42 (1H, s), and δ=8.21-8.12 (6H, m), δ=8.04 (2H, d, J=7.99), and δ=7.83 (2H, s, J=8.06), δ=7.83 (2H, d, J=1.63), δ=7.74 (1H, t, J=7.74), δ=7.54 (2H, t, J=7.50), δ=7.44 (4H, d, J=7.23), δ=1.43 (9H, s) MALDI-TOF, m/z:671.5, ultimate analysis (C 38H 30N 4O 4S 2): C 0.6804, and H 0.0451, and N 0.0835; Measured value: C 0.6784, H 0.0469, and N 0.0820.Equally, as shown in Figure 2, the characteristic feature that the big stokes displacement of 150nm is an excited state molecule inner proton transfer compounds.Dotted line shows that its fusing point is respectively 322 ℃ in the differential calorimetric scanning curve of Fig. 3, and dotted line is shown in the thermogravimetric curve of Fig. 4 does not almost have the thermogravimetric loss below 380 ℃, illustrated that equally this compound has higher decomposition temperature and good thermostability.In addition as shown in Figure 6 product in state of aggregation or the fluorescent emission intensity when solid-state much larger than its luminous intensity in solution, can be applicable to the organic molecule field of light emitting materials.
Embodiment 6
Preparation N, N '-two (3-hydroxyl-4-(2 '-benzo Dumb azoles) phenyl) isophthaloyl amine, its molecular structural formula is:
Figure A20071009896700121
X=O wherein, Y=2, R=
Figure A20071009896700122
Change 2-among the embodiment 4 (4-amino-2 hydroxy phenyl) benzothiazole into 2-(4-amino-2 hydroxy phenyl) benzo Dumb azoles, CDI is changed to 5.5mmol, toluene 50ml, and 2-(4-amino-2 hydroxy phenyl) benzothiazole is changed to 7mmol, and other step is with embodiment 4.Head product CH 2Cl 2/ CH 3OH (v/v=10: 1) purify, and productive rate is 73% by the mixed solvent washing.℃ M.p.>300 1H-NMR (400Hz, [D 6] DMSO, 25 ℃, TMS) δ=11.28 (s, 2H), δ=10.73 (2H, s), and δ=8.57 (1H, s), δ=8.20 (2H, d, J=8.41), δ=8.05 (2H, d, J=8.76), and δ=7.84 (4H, t, J=4.53), δ=7.77 (3H, m), δ=7.55 (2H, d, J=8.70), and δ=7.46 (4H, d, J=4.35); MALDI-TOF, m/z:583.4[M+H] +Ultimate analysis (C 34H 22N 4O 6): C, 70.10; H, 3.81; N, 9.62; Measured value: 69.83, H 4.04, and N 9.31.
Embodiment 7
N, N '-two (3-hydroxyl-4-(2 '-benzo Dumb azoles) phenyl) 5-methyl-isophthaloyl amine, its molecular structural formula is:
Figure A20071009896700123
X=O wherein, Y=2, R=
Figure A20071009896700124
Change 2-among the embodiment 4 (4-amino-2 hydroxy phenyl) benzothiazole into 2-(4-amino-2 hydroxy phenyl) benzo Dumb azoles, m-phthalic acid changes 5-methyl-m-phthalic acid into, CDI is changed to 7.5mmol, toluene 15ml, 2-(4-amino-2 hydroxy phenyl) benzo Dumb azoles is changed to other steps of 6mmol with embodiment 4.Head product CH 2Cl 2Solvent wash is purified, and productive rate is 71%.Compound M.p.>300 ℃. 1H-NMR (300Hz, [D 6] DMSO, 25 ℃, TMS). δ=11.29 (2H, s), 10.70 (2H, s), 8.37 (1H, s), 8.04 (2H, d, J=8.42), 8.03 (2H, d, J=8.76), 7.84 (4H, t, J=4.05), 7.77 (2H, s), 7.55 (2H, d, J=8.52), 7.46 (4H, d, J=4.08, phenyl), 2.53 (3H, s) MALDI-TOF, m/z:597.3[M+H] +, ultimate analysis (C 35H 24N 4O 6): C 70.46; H 4.05, and N 9.39; Measured value: 70.17, H 4.26, and N 9.50.
Embodiment 8
Preparation N, N '-two (3-hydroxyl-4-(2 '-benzo Dumb azoles) phenyl) the 5-tertiary butyl-isophthaloyl amine, its molecular structural formula is:
Figure A20071009896700131
X=O wherein, Y=2, R=
Figure A20071009896700132
Change 2-among the embodiment 4 (4-amino-2 hydroxy phenyl) benzothiazole into 2-(4-amino-2 hydroxy phenyl) benzo Dumb azoles, m-phthalic acid changes the 5-tertiary butyl-m-phthalic acid into, and other step is with embodiment 4.Head product CH 2Cl 2Solvent wash is purified, and productive rate is 70%.Compound M.p.242 ℃. 1H-NMR (300Hz, [D 6] DMSO, 25 ℃, TMS). δ=11.29 (2H, s), 10.69 (2H, s), 8.41 (1H, s), 8.17 (2H, s), 8.06 (2H, d, J=8.76), 7.84 (4H, t, J=4.35), 7.77 (2H, s), 7.55 (2H, d, J=8.72), 7.46 (4H, d, J=4.08, phenyl), 1.43 (9H, s); MS (MALDI-TOF), m/z:639.3[M+H] +Ultimate analysis (C 38H 30N 4O): C 71.46, and H 4.73, and N 8.77; Measured value: C 70.97, H 4.79, and N 8.40.
Embodiment 9
Preparation N, N '-two (3-hydroxyl-4-(2 '-benzo Dumb azoles) phenyl) terephthalamide, its molecular structural formula is:
Figure A20071009896700133
X=O wherein, Y=2, R=
Figure A20071009896700134
Change m-phthalic acid among the embodiment 4 into terephthalic acid, 2-(4-amino-2 hydroxy phenyl) benzothiazole changes 2-(4-amino-2 hydroxy phenyl) benzo Dumb azoles into, CDI 4.5mmol, 2-(4-amino-2 hydroxy phenyl) benzo Dumb azoles is changed to 4mmol, and other step is with embodiment 4.Head product CH 2Cl 2/ CH 3OH (v/v=10: 1) purify, and productive rate is 86% by the mixed solvent washing.Compound M.p.>300 ℃ .MS (MALDI-TOF), m/z:583.4[M+H] +Ultimate analysis (C 34H 22N 4O 6): C, 70.10; H, 3.81; N, 9.62; Measured value: C 70.23, H 3.79, and N 9.42.
Embodiment 10
Preparation N-(3-hydroxyl-4-(2 '-benzo Dumb azoles) phenyl)-3-carboxyl-benzamide, its molecular structural formula is:
Figure A20071009896700141
X=O wherein, Y=1, R=
Figure A20071009896700142
Change m-phthalic acid among the embodiment 4 into terephthalic acid, 2-(4-amino-2 hydroxy phenyl) benzothiazole changes 2-(4-amino-2 hydroxy phenyl) benzo Dumb azoles into, CDI 2.25mmol, 2-(4-amino-2 hydroxy phenyl) benzo Dumb azoles 2mmol, solvent toluene is changed to tetrahydrofuran (THF), tetrahydrofuran (THF) 25ml.Other step is with embodiment 4.Head product CH 2Cl 2/ CH 3(v/v=10: 1) mixed solvent is crossed silicagel column as leacheate to OH.Compound M.p.>300 ℃. 1H-NMR (300Hz, [D 6] DMSO, 25 ℃, TMS). δ=11.25 (1H, s), δ=10.84 (1H, s), δ=7.98 (1H, d, J=8.6), and δ=7.91 (1H, d, J=7.3), δ=7.90-7.84 (2H, m), δ=7.70 (1H, s), δ=7.67 (1H, d, J=7.6), δ=7.61 (2H, t, J=7.0), δ=7.47-7.44 (2H, m); δ=7.37 (1H, d, J=8.6); MS (MALDI-TOF), m/z:375.4[M+H] +Ultimate analysis (C 21H 14N 2O 5): C, 67.38; H, 3.77; N, 7.48; Measured value: C 67.21, H 3.69, and N 7.40.
Embodiment 11
Preparation N, N '-two (3-hydroxyl-4-(2 '-benzothiazole) phenyl) 1,7-pimeloyl amine, its molecular structural formula is:
Figure A20071009896700143
X=S wherein, Y=2, R=
Change m-phthalic acid among the embodiment 4 into pimelic acid, other step is with embodiment 4.Head product CH 2Cl 2/ CH 3(v/v=10: 1) mixed solvent washs and obtains purifying OH.Compound M.p.>300 ℃. 1H-NMR (400Hz, d-DMSO) δ=11.61 (2H, s), δ=10.13 (2H, s), δ=8.43 (1H, s), δ=8.09 (4H, m), δ=8.00 (2H, d, J=8.0), δ=7.72 (1H, s), δ=7.61 (2H, s), and δ=7.52 (2H, t, J=7.6), δ=7.41 (2H, d, J=7.6), δ=2.37 (4H, t, J=7.2), δ=1.73-1.64 (6H, m); MALDI-TOF, m/z:609.4, ultimate analysis (C 33H 28N 4O 4S 2): C, 65.11; H, 4.64; N, 9.20; Measured value: C 64.86, H 4.71, and N 9.24.
Embodiment 12
Preparation N-(3-hydroxyl-4-(2 '-benzoglyoxaline) phenyl)-4-carboxyl-benzamide, its molecular structural formula is:
Figure A20071009896700151
X=NH wherein, Y=1, R=
Figure A20071009896700152
Change m-phthalic acid among the embodiment 4 into terephthalic acid, 2-(4-amino-2 hydroxy phenyl) benzothiazole changes 2-(4-amino-2 hydroxy phenyl) benzoglyoxaline into, solvent toluene is changed to tetrahydrofuran (THF), CDI is changed to 3.75mmol, 2-(4-amino-2 hydroxy phenyl) benzoglyoxaline 3.5mmol, tetrahydrofuran (THF) 7.5ml, other step is with embodiment 4.Filter gained crude product methylene dichloride (CH 2Cl 2) the solvent repeated washing.Change other steps with embodiment 4.Head product CH 2Cl 2/ CH 3(v/v=10: 1) mixed solvent is crossed silicagel column as leacheate to OH.Compound M.p.>300 ℃. 1H-NMR (400Hz, d-DMSO) δ=13.18 (1H, s), δ=11.65 (1H, s), δ=8.10 (2H, d, J=4.4), and δ=8.01 (1H, m), δ=7.74 (3H, d, J=5.8), δ=7.51 (1H, d, J=9.8), δ=7.43 (3H, m), δ=7.25 (1H, d, J=7.9); δ=5.42 (1H, s); MALDI-TOF, m/z:375.4, ultimate analysis (C 21H 15N 3O 4): C, 67.56; H, 4.05; N, 11.25; Measured value: C 67.48, H 4.01, and N 11.31.
Embodiment 13
Preparation N, N ', N " the equal benzene trimethamide of-three (3-hydroxyl-4-(2 '-benzo Dumb azoles) phenyl), its molecular structural formula is:
Figure A20071009896700153
X=O wherein, Y=3, R=
Figure A20071009896700154
Change m-phthalic acid among the embodiment 4 into trimesic acid, 2-(4-amino-2 hydroxy phenyl) benzothiazole changes 2-(4-amino-2 hydroxy phenyl) benzo Dumb azoles .CDI 12mmol into, 2-(4-amino-2 hydroxy phenyl) benzo Dumb azoles 10.5mmol, toluene solvant 55ml, other step is with embodiment 4.Head product CH 2Cl 2/ CH 3(v/v=10: 1) mixed solvent is crossed silicagel column as leacheate to OH.Compound M.p.>300 ℃. 1H-NMR (400Hz, d-DMSO) δ=11.88 (3H, s), δ=11.45 (3H, s), δ=7.98 (3H, d, J=8.1), δ=7.85 (3H, d, J=7.6), δ=7.90-7.84 (6H, m), δ=7.72 (3H, s), δ=7.47-7.44 (6H, m); δ=7.37 (3H, d, J=8.6) MALDI-TOF, m/z:883.4, ultimate analysis (C 48H 30N 6O 6S 3): C, 65.29; H, 3.42; N, 9.52; Measured value: C 65.25, H 3.38, N 9.50.0.
Embodiment 14
Preparation N-(3-hydroxyl-4-(2 '-benzoglyoxaline) phenyl)-2-carboxyl-benzamide, its molecular structural formula is:
Figure A20071009896700161
X=NH wherein, Y=1, R=
Figure A20071009896700162
Change m-phthalic acid among the embodiment 4 into phthalic acid, 2-(4-amino-2 hydroxy phenyl) benzothiazole changes 2-(4-amino-2 hydroxy phenyl) benzoglyoxaline into, solvent is changed to tetrahydrofuran (THF), CDI is changed to 6.5mmol, 2-(4-amino-2 hydroxy phenyl) benzoglyoxaline 3mmol, tetrahydrofuran (THF) 50ml, other step is with embodiment 4.Filter the gained crude product with head product CH 2Cl 2/ CH 3(v/v=10: 1) mixed solvent is crossed silicagel column as leacheate to OH.Compound M.p.>300 ℃. 1H-NMR (300Hz, d-DMSO) δ=11.83 (1H, s), δ=11.58 (1H, s), and δ=8.33 (1H, d, J=8.5), δ=8.15 (1H, d, J=7.9), δ=8.07 (1H, d, J=8.1), δ=8.00-7.96 (2H, m), and δ=7.94-7.90 (2H, m), δ=7.57 (1H, t, J=3.8); δ=7.44 (1H, t, J=3.7); δ=7.23 (1H, s); δ=7.15 (1H, d, J=8.4); δ=6.49 (1H, s); MALDI-TOF, m/z:375.4, ultimate analysis (C 21H 15N 3O 4): C, 67.56; H, 4.05; N, 11.25; Measured value: C 67.48, H4.01, N 11.31.

Claims (9)

1. amides based on 2-(2 '-hydroxy phenyl) benzothiazole is characterized in that this structural general formula is:
Figure A2007100989670002C1
Wherein X is S, O or NH;
During Y=1, R is
Figure A2007100989670002C2
Figure A2007100989670002C3
Wherein: Me is a methyl; TBu is the tertiary butyl;
During Y=2, R is Wherein:
Me is a methyl; TBu is the tertiary butyl;
During Y=3, R is
2. the method for making of the amides based on 2-(2 '-hydroxy phenyl) benzothiazole according to claim 1, it is characterized in that: carboxylic acid and carbonyl dimidazoles are joined in the reaction solvent, under 25~40 ℃ of temperature, reacted 1~3 hour, the aminated compounds that adds 2-(2 '-hydroxy phenyl) benzothiazole again, reacted 2~14 hours under 25~130 ℃ of temperature, filtration, purifying obtain the amides based on 2-(2 '-hydroxy phenyl) benzothiazole;
Described carboxylic acid structure general formula is:
Figure A2007100989670002C6
During Y=1, R is Wherein: Me is a methyl; TBu is the tertiary butyl;
During Y=2, R is
Figure A2007100989670003C3
Wherein:
Me is a methyl; TBu is the tertiary butyl;
During Y=3, R is
Figure A2007100989670003C4
When Y=1, reaction solvent is an anhydrous tetrahydro furan; When Y=2 or 3, reaction solvent is a dry toluene.
3. method for making according to claim 2, it is characterized in that: count in molar ratio, the ratio of described carboxylic acid and carbonyl dimidazoles is 1: 0.9Y~1.5Y, the ratio of the aminated compounds of described carboxylic acid and 2-(2 '-hydroxy phenyl) benzothiazole is 1: 0.5Y~1.4Y, wherein Y=1,2 or 3.
4. method for making according to claim 3 is characterized in that: count in molar ratio, the ratio of described carboxylic acid and carbonyl dimidazoles is 1: 1.2Y; The ratio of the aminated compounds of described carboxylic acid and 2-(2 '-hydroxy phenyl) benzothiazole is 1: 1Y, wherein Y=1,2 or 3.
5. according to claim 2,3 or 4 described method for makings, it is characterized in that: the general structure of the aminated compounds of described 2-(2 '-hydroxy phenyl) benzothiazole is:
Figure A2007100989670003C5
Wherein X is S, O or NH.
6. method for making according to claim 2 is characterized in that: the ratio of described carboxylic acid and reaction solvent is 1 mole: 3Y~10Y liter; Y=1,2 or 3 wherein.
7. method for making according to claim 6 is characterized in that: the ratio of described carboxylic acid and reaction solvent is 1 mole: 4Y~7Y liter.
8. according to claim 2,3,4,6 or 7 described method for makings, it is characterized in that: described carboxylic acid is pimelic acid, phthalic acid, m-phthalic acid, oreinol dioctyl phthalate, 5-tert-butyl isophthalic acid, terephthalic acid or trimesic acid.
9. the purposes of the amides based on 2-(2 '-hydroxy phenyl) benzothiazole according to claim 1, it is characterized in that: described compound is used to prepare luminous organic material.
CN2007100989678A 2007-04-30 2007-04-30 Acidamide compound based on 2-(2'-hydroxyphenyl) benzoxazole, preparation and use thereof Expired - Fee Related CN101298442B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007100989678A CN101298442B (en) 2007-04-30 2007-04-30 Acidamide compound based on 2-(2'-hydroxyphenyl) benzoxazole, preparation and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007100989678A CN101298442B (en) 2007-04-30 2007-04-30 Acidamide compound based on 2-(2'-hydroxyphenyl) benzoxazole, preparation and use thereof

Publications (2)

Publication Number Publication Date
CN101298442A true CN101298442A (en) 2008-11-05
CN101298442B CN101298442B (en) 2010-07-07

Family

ID=40078415

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007100989678A Expired - Fee Related CN101298442B (en) 2007-04-30 2007-04-30 Acidamide compound based on 2-(2'-hydroxyphenyl) benzoxazole, preparation and use thereof

Country Status (1)

Country Link
CN (1) CN101298442B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102250134A (en) * 2010-05-21 2011-11-23 中国科学院化学研究所 Fluorescent probe for identifying fluorine ions and preparation method and use thereof
CN102676159A (en) * 2012-05-25 2012-09-19 南京邮电大学 White-light nano particle preparation method
JP2013527170A (en) * 2010-05-06 2013-06-27 インコゼン セラピューティクス プライベート リミテッド Novel immunomodulators and anti-inflammatory compounds
CN103467410A (en) * 2013-07-17 2013-12-25 大连大学 Fluorescent probe compound used for detection of acetate, and applications thereof
CN105712950A (en) * 2016-01-27 2016-06-29 中国科学院化学研究所 Benzothiazole-based amide compound and preparation method and application thereof
CN107109227A (en) * 2014-09-30 2017-08-29 光学转变公司 UV absorbers
CN109943321A (en) * 2019-04-09 2019-06-28 南京邮电大学 ESIPT luminescent material and the preparation method and application thereof with delayed fluorescence property
CN111825696A (en) * 2019-04-18 2020-10-27 中国科学院化学研究所 Benzoxazole ion compound, PBO fiber emulsion sizing agent containing benzoxazole ion compound and preparation method of PBO fiber emulsion sizing agent

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104592498B (en) * 2014-10-29 2018-07-31 上海新微科技发展有限公司 A kind of compound and its preparation method and application can detect a variety of amine steams

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100591184C (en) * 2004-03-15 2010-02-17 新日铁化学株式会社 Organic electroluminescent element

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013527170A (en) * 2010-05-06 2013-06-27 インコゼン セラピューティクス プライベート リミテッド Novel immunomodulators and anti-inflammatory compounds
CN102250134B (en) * 2010-05-21 2013-12-04 中国科学院化学研究所 Fluorescent probe for identifying fluorine ions and preparation method and use thereof
CN102250134A (en) * 2010-05-21 2011-11-23 中国科学院化学研究所 Fluorescent probe for identifying fluorine ions and preparation method and use thereof
CN102676159A (en) * 2012-05-25 2012-09-19 南京邮电大学 White-light nano particle preparation method
CN103467410A (en) * 2013-07-17 2013-12-25 大连大学 Fluorescent probe compound used for detection of acetate, and applications thereof
CN103467410B (en) * 2013-07-17 2016-03-30 大连大学 A kind of acetate fluorescent probe compounds and application thereof
US10619098B2 (en) * 2014-09-30 2020-04-14 Transitions Optical, Inc. Ultraviolet light absorbers
CN107109227A (en) * 2014-09-30 2017-08-29 光学转变公司 UV absorbers
CN105712950A (en) * 2016-01-27 2016-06-29 中国科学院化学研究所 Benzothiazole-based amide compound and preparation method and application thereof
CN105712950B (en) * 2016-01-27 2019-05-21 中国科学院化学研究所 Amides compound and its preparation method and application based on benzothiazole
CN109943321A (en) * 2019-04-09 2019-06-28 南京邮电大学 ESIPT luminescent material and the preparation method and application thereof with delayed fluorescence property
CN111825696A (en) * 2019-04-18 2020-10-27 中国科学院化学研究所 Benzoxazole ion compound, PBO fiber emulsion sizing agent containing benzoxazole ion compound and preparation method of PBO fiber emulsion sizing agent
CN111825696B (en) * 2019-04-18 2021-10-29 中国科学院化学研究所 Benzoxazole ion compound, PBO fiber emulsion sizing agent containing benzoxazole ion compound and preparation method of PBO fiber emulsion sizing agent

Also Published As

Publication number Publication date
CN101298442B (en) 2010-07-07

Similar Documents

Publication Publication Date Title
CN101298442B (en) Acidamide compound based on 2-(2'-hydroxyphenyl) benzoxazole, preparation and use thereof
CA2728058C (en) Process for the manufacture of an intermediate product of dabigatran etexilate
CN102702096B (en) Quinoline nitrile derivative with aggregation-induced emission performance
CN103058942B (en) One-pot synthetic method for 1,2,3-triazole compounds
CN111825634B (en) Novel compounds, process for their preparation and their use
CN103224436B (en) The preparation method of the amino diaryl ketone compound of a kind of neighbour
CN111303010A (en) Organic room temperature phosphorescent material containing imide structure, preparation method and application thereof
Khazdooz et al. A study for the synthesis of dibenzo [a, j] xanthenes and 1-amidoalkyl 2-naphthols catalyzed by [Hmim][HSO4] as a green, efficient and reusable catalyst under solvent-free conditions
CN109320507B (en) Chiral fluorescent compound based on quinoline amide folder and preparation method and application thereof
CN113264843B (en) Synthetic method of 3-aminobicyclo [1.1.1] pentane-1-carboxylic ester derivative
CN103555320B (en) A kind of Phosphaphenanthryl benzoxazole ultraviolet luminescent material and preparation method thereof
CN113416162B (en) Double-chiral binaphthyl O-N-N tridentate ligand and preparation method thereof
RU2409555C1 (en) Method for synthesis of 4-(3,4-diaminophenoxy)benzoic acid esters
CN100516039C (en) Method for mass preparation of formamide phenol compound
CN110878055B (en) Method for preparing carbonyl heterocyclic compound
CN103709116B (en) A kind of preparation method of 4-(4-alkoxycarbonylamino) phenyl-3-morpholone mai
CN1454891A (en) Benzimidazole and its derivative synthetic method
CN108047087B (en) 3 '- (4-bromonaphthalene-1-yl) [1, 1' -biphenyl ] -4-nitrile and synthesis method thereof
CN104311469A (en) Synthetic method of substituted indole-3-acetic acid
CN102584610B (en) Bisphenol 2 (m-amino p-hydroxy phenyl) ether hydrochloride and preparation method and application thereof
KR101457453B1 (en) Process for preparing gefitinib and an intermediate used for preparing thereof
Arifuddin et al. Zinc chloride promoted efficient and facile BOC protection of amines
Zhu et al. Hydrogen bonding-mediated self-assembly of anthranilamide-based homodimers through preorganization of the amido and ureido binding sites
JP6909096B2 (en) Method for forming catalyst, amide bond, and method for producing amide compound
KR101653532B1 (en) Synthesis of Benzimidazoles bearing borionic acid functionality via metal-free aerobic oxidation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100707

Termination date: 20140430